摘要
目的观察丹参酮ⅡA磺酸钠联合硫酸氢氯吡格雷治疗心绞痛的临床疗效。方法 2011年1月至2012年9月,70例不稳定型心绞痛患者随机分成两组,均给予心绞痛内科常规治疗,对照组给予丹参酮ⅡA磺酸钠注射液静脉滴注40mg/d,治疗组在对照组的基础上加服硫酸氢氯吡格雷75mg/d,疗程2周。结果对照组有效率68.57%,治疗组82.86%,治疗组优于对照组(P<0.05)。结论丹参酮ⅡA磺酸钠联合硫酸氢氯吡格雷治疗不稳定型心绞痛疗效确切。
Objective To observe the effect that the sulfotanshinone sodium unite clopidogrel bisulfate treat angina.Method From January,2011 to September,2012,there are 70 unstable angina pectoris,random being divided into 2 groups.2 groups all give the angina Medicine normal regulations to cure,The control group give the injection sulfotanshinone sodium（40mg/d,ivgtt）,on the basal,The treatment group useing clopidogrel bisulfate（75mg,po,qd）to treat,treatment for 2 weeks.Result Curative effect of the treatment group obviously surpasses the control group（P 0.05）.Conclusion In curing the unstable angina,the effect of sulfotanshinone sodium unites clopidogrel bisulfate is affirmation.
出处
《中国医药指南》
2012年第36期416-417,共2页
Guide of China Medicine
